Compounds > tetrachloroisophthalonitrile
Page last updated: 2024-08-21

tetrachloroisophthalonitrile and Bleeding

tetrachloroisophthalonitrile has been researched along with Bleeding in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Anthopoulos, P; Cao, D; Chen, S; Dangas, G; Dumonteil, N; Feldman, D; Ferrari, M; Hengstenberg, C; Jeger, R; Mehran, R; Meneveau, N; Nicolas, J; Razuk, V; Sartori, S; Spirito, A; Stella, PR; Tron, C; Violini, R; Vogel, B; Widder, JD; Yan, R; Zhang, Z1
Adler, DG; Bhandari, P; Chandan, S; Facciorusso, A; Gkolfakis, P; Kewalramani, A; Mozell, D; Ramai, D; Swaminath, A1

Trials

1 trial(s) available for tetrachloroisophthalonitrile and Bleeding

ArticleYear
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2023, Volume: 101, Issue:6

    Topics: Antithrombins; Coronary Artery Disease; Hemorrhage; Heparin; Hirudins; Humans; Peptide Fragments; Recombinant Proteins; Transcatheter Aortic Valve Replacement; Treatment Outcome

2023

Other Studies

1 other study(ies) available for tetrachloroisophthalonitrile and Bleeding

ArticleYear
Patient adverse events and technical failures with the bravo capsule pH system: insights from the MAUDE database.
    Esophagus : official journal of the Japan Esophageal Society, 2023, Volume: 20, Issue:4

    Topics: Hemorrhage; Humans; Hydrogen-Ion Concentration

2023